Published in Blood Weekly, July 15th, 2004
In nine presentations at the annual meeting of the International Society for Stem Cell Research (ISSCR) in Boston, Massachusetts, Geron and its collaborators reported advancements in the differentiation of hESCs to therapeutic cell types, the engraftment of these differentiated cells in animal models, and the production of cells for eventual clinical testing.
Adding to the list of prospective therapeutic cells already produced from hESCs, Geron scientists demonstrated the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.